Results 1 to 10 of about 24,770 (274)

Monitoring Serum Bisoprolol Concentrations in Patients With Heart Failure With Reduced Ejection Fraction: Results of a Pilot Study From Routine Health Care [PDF]

open access: yesPharmacology Research & Perspectives
Bisoprolol is a second‐generation, highly selective beta‐1 adrenergic receptor antagonist with various beneficial effects in patients with heart failure.
Ivana Kacirova   +5 more
doaj   +2 more sources

The Influence of EGCG on the Pharmacokinetics and Pharmacodynamics of Bisoprolol and a New Method for Simultaneous Determination of EGCG and Bisoprolol in Rat Plasma

open access: yesFrontiers in Nutrition, 2022
Background and AimResearch has shown that green tea catechins may influence the activity of drug metabolizing enzymes and drug transporters. We examined whether epigallocatechin-3-gallate (EGCG) affected the pharmacokinetics and pharmacodynamics of ...
Weiwei Zeng   +12 more
doaj   +3 more sources

Tolerability of Bisoprolol on Domiciliary Spirometry in COPD [PDF]

open access: yesLung, 2018
We investigated if serial domiciliary measures of spirometry were sensitive at detecting subtle effects of beta-2 blockade associated with bisoprolol in (n = 17) patients with COPD.
B Lipworth   +12 more
core   +6 more sources

Bisoprolol and Nifedipine SR in the Treatment of Hypertension in the Elderly

open access: bronzeJournal of Cardiovascular Pharmacology, 1990
Forty outpatients (11 men and 29 women) aged between 65 and 85 years (mean age of 68 years) with mild to moderate hypertension [mean systolic/diastolic blood pressure (SBP/DBP) after 2 weeks on placebo of 175/102 mm Hg] were included in a randomized, double-blind, parallel-group study to compare the efficacy and tolerance of 10 mg of bisoprolol once ...
M. J. Miranda García   +5 more
openaire   +4 more sources

The influence of edema on the bisoprolol blood concentration after bisoprolol dermal patch application

open access: goldMedicine, 2021
Abstract Background: Beta-blocking is important for critically ill patients. Although some patients are required to continue taking beta-blockers after they no longer need critical care, some of these patients have impaired swallowing abilities.
Yuji Takahashi   +5 more
openaire   +3 more sources

Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT

open access: yesHealth Technology Assessment
Background Observational studies of people with chronic obstructive pulmonary disease using beta-blockers for cardiovascular disease indicate that beta-blocker use is associated with reduced risk of chronic obstructive pulmonary disease exacerbation ...
Graham Devereux   +22 more
doaj   +2 more sources

Bisoprolol in the treatment of chronic heart failure

open access: yesVascular Health and Risk Management, 2007
Pascal de Groote1, Pierre-Vladimir Ennezat2, Fréderic Mouquet11Service de Cardiologie C, 2Service des soins intensifs cardiologiques, Hôpital Cardiologique, Centre Hospitalier Régional et Universitaire de Lille, FranceAbstract ...
Pascal de Groote   +2 more
doaj   +2 more sources

Potential application of bisoprolol derivative compounds as antihypertensive drugs: synthesis and in silico study

open access: yesRoyal Society Open Science, 2023
Two bisoprolol derivatives, N-acetyl bisoprolol and N-formyl bisoprolol, belonging to the beta-blocker class of antihypertensive drugs, were synthesized using acetylation and formylation reactions. The yields of the reactions were determined to be 32.40%
Ni Putu Sani Oktaviani   +5 more
doaj   +1 more source

Forced degradation studies and structural characterization of related substances of bisoprolol fumarate in finished drug product using LC-UV-MS/MS [PDF]

open access: yesJournal of the Serbian Chemical Society, 2022
Methods for determination of bisoprolol and related substances mostly use UV detection and a phosphate buffer and are not suitable for MS detection.
Lazarevska-Todevska Elena   +2 more
doaj   +1 more source

Bisoprolol in the treatment of hypertension in the elderly [PDF]

open access: yesJournal of Human Hypertension, 1998
The aim of the study was to examine the hypotensive efficacy and tolerance of bisoprolol in elderly patients. Sixty patients (40 65 years) with mild-to-moderate essential hypertension (diastolic blood pressure (DBP) between 95 and 109 mm Hg) were included in the study.
M Broncel   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy